Serial labeling index determination as a predictor of response in human solid tumors

W. K. Murphy, Robert B Livingston, V. G. Ruiz, F. G. Gercovich, S. L. George, J. S. Hart, E. J. Freireich

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

A rapid method for determining labeling indices in solid tumor specimens, tumor induced effusions, and tumor bearing bone marrows was utilized in 116 patients. Of these, 48 patients were studied pre and postchemotherapy. The magnitude of a significant change in labeling index (LI%) was determined statistically. Of the 48 patients studied serially, 42 were studied 17 days or less following completion of their chemotherapy. In 26 patients without a significant change in tumor LI%, there was no subsequent clinical response to chemotherapy. Three additional patients in this group are inevaluable at present. In 11 patients, there was a significant fall in tumor LI% following chemotherapy. Seven of these had a 50% or greater regression of demonstrable disease, one patient had definite tumor effect but the effect was not a partial response and three patients were not evaluable for clinical response. In two patients there was a significant increase in tumor LI% and the patients had rapid tumor progression and death. Predictions derived from serial study of the LI% by this method correlate significantly with subsequent behavior of the tumors tested following chemotherapy and may prove clinically useful in making decisions about when or whether to change therapy.

Original languageEnglish (US)
Pages (from-to)1438-1444
Number of pages7
JournalCancer Research
Volume35
Issue number6
StatePublished - 1975
Externally publishedYes

Fingerprint

Neoplasms
Drug Therapy
Decision Making
Bone Marrow
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Murphy, W. K., Livingston, R. B., Ruiz, V. G., Gercovich, F. G., George, S. L., Hart, J. S., & Freireich, E. J. (1975). Serial labeling index determination as a predictor of response in human solid tumors. Cancer Research, 35(6), 1438-1444.

Serial labeling index determination as a predictor of response in human solid tumors. / Murphy, W. K.; Livingston, Robert B; Ruiz, V. G.; Gercovich, F. G.; George, S. L.; Hart, J. S.; Freireich, E. J.

In: Cancer Research, Vol. 35, No. 6, 1975, p. 1438-1444.

Research output: Contribution to journalArticle

Murphy, WK, Livingston, RB, Ruiz, VG, Gercovich, FG, George, SL, Hart, JS & Freireich, EJ 1975, 'Serial labeling index determination as a predictor of response in human solid tumors', Cancer Research, vol. 35, no. 6, pp. 1438-1444.
Murphy WK, Livingston RB, Ruiz VG, Gercovich FG, George SL, Hart JS et al. Serial labeling index determination as a predictor of response in human solid tumors. Cancer Research. 1975;35(6):1438-1444.
Murphy, W. K. ; Livingston, Robert B ; Ruiz, V. G. ; Gercovich, F. G. ; George, S. L. ; Hart, J. S. ; Freireich, E. J. / Serial labeling index determination as a predictor of response in human solid tumors. In: Cancer Research. 1975 ; Vol. 35, No. 6. pp. 1438-1444.
@article{e96be8fce11f41078de9256302e8721a,
title = "Serial labeling index determination as a predictor of response in human solid tumors",
abstract = "A rapid method for determining labeling indices in solid tumor specimens, tumor induced effusions, and tumor bearing bone marrows was utilized in 116 patients. Of these, 48 patients were studied pre and postchemotherapy. The magnitude of a significant change in labeling index (LI{\%}) was determined statistically. Of the 48 patients studied serially, 42 were studied 17 days or less following completion of their chemotherapy. In 26 patients without a significant change in tumor LI{\%}, there was no subsequent clinical response to chemotherapy. Three additional patients in this group are inevaluable at present. In 11 patients, there was a significant fall in tumor LI{\%} following chemotherapy. Seven of these had a 50{\%} or greater regression of demonstrable disease, one patient had definite tumor effect but the effect was not a partial response and three patients were not evaluable for clinical response. In two patients there was a significant increase in tumor LI{\%} and the patients had rapid tumor progression and death. Predictions derived from serial study of the LI{\%} by this method correlate significantly with subsequent behavior of the tumors tested following chemotherapy and may prove clinically useful in making decisions about when or whether to change therapy.",
author = "Murphy, {W. K.} and Livingston, {Robert B} and Ruiz, {V. G.} and Gercovich, {F. G.} and George, {S. L.} and Hart, {J. S.} and Freireich, {E. J.}",
year = "1975",
language = "English (US)",
volume = "35",
pages = "1438--1444",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Serial labeling index determination as a predictor of response in human solid tumors

AU - Murphy, W. K.

AU - Livingston, Robert B

AU - Ruiz, V. G.

AU - Gercovich, F. G.

AU - George, S. L.

AU - Hart, J. S.

AU - Freireich, E. J.

PY - 1975

Y1 - 1975

N2 - A rapid method for determining labeling indices in solid tumor specimens, tumor induced effusions, and tumor bearing bone marrows was utilized in 116 patients. Of these, 48 patients were studied pre and postchemotherapy. The magnitude of a significant change in labeling index (LI%) was determined statistically. Of the 48 patients studied serially, 42 were studied 17 days or less following completion of their chemotherapy. In 26 patients without a significant change in tumor LI%, there was no subsequent clinical response to chemotherapy. Three additional patients in this group are inevaluable at present. In 11 patients, there was a significant fall in tumor LI% following chemotherapy. Seven of these had a 50% or greater regression of demonstrable disease, one patient had definite tumor effect but the effect was not a partial response and three patients were not evaluable for clinical response. In two patients there was a significant increase in tumor LI% and the patients had rapid tumor progression and death. Predictions derived from serial study of the LI% by this method correlate significantly with subsequent behavior of the tumors tested following chemotherapy and may prove clinically useful in making decisions about when or whether to change therapy.

AB - A rapid method for determining labeling indices in solid tumor specimens, tumor induced effusions, and tumor bearing bone marrows was utilized in 116 patients. Of these, 48 patients were studied pre and postchemotherapy. The magnitude of a significant change in labeling index (LI%) was determined statistically. Of the 48 patients studied serially, 42 were studied 17 days or less following completion of their chemotherapy. In 26 patients without a significant change in tumor LI%, there was no subsequent clinical response to chemotherapy. Three additional patients in this group are inevaluable at present. In 11 patients, there was a significant fall in tumor LI% following chemotherapy. Seven of these had a 50% or greater regression of demonstrable disease, one patient had definite tumor effect but the effect was not a partial response and three patients were not evaluable for clinical response. In two patients there was a significant increase in tumor LI% and the patients had rapid tumor progression and death. Predictions derived from serial study of the LI% by this method correlate significantly with subsequent behavior of the tumors tested following chemotherapy and may prove clinically useful in making decisions about when or whether to change therapy.

UR - http://www.scopus.com/inward/record.url?scp=0016823385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016823385&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 1438

EP - 1444

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 6

ER -